M1228Medical Services
Patient, who has a reactive hcv antibody test, and has a follow up hcv viral
Short description: Pt + hcv aby +vir w/ rx 3 mo
- Effective date
- January 1, 2024
- Termination date
- —
Related codes (M-series)
M0001Advancing cancer care mvpM0002Opt care kidney hlth mvpM0003Opt care episod neuro mvpM0004Qual care neurologic cnd mvpM0005Value in primary care mvpM0010Eom meos paymentM0064Visit for drug monitoringM0075Cellular therapyM0076ProlotherapyM0100Intragastric hypothermiaM0201Pne flu hepb cov home adminM0220Tixagev and cilgav inj
Frequently asked questions
What is HCPCS code M1228?
M1228 is a HCPCS Level II code for Patient, who has a reactive hcv antibody test, and has a follow up hcv viral.
What category is HCPCS code M1228 in?
M1228 falls under the Medical Services category of HCPCS Level II.
When did HCPCS code M1228 become effective?
M1228 has been effective since January 1, 2024, per CMS's quarterly HCPCS update.
HCPCS Level II data from CMS (public domain). HCPCS Level I (CPT) codes are not included — CPT is copyrighted by the American Medical Association. Always verify codes with authoritative sources before making coding or billing decisions.